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ABSTRACT 35 
The aim of the present study was to assess the effects of pomegranate juice on the level of oxidative 36 
stress in blood of endurance-based athletes. Pomegranate juice is rich in polyphenols, conferring it a 37 
higher antioxidant capacity than other beverages with polyphenolic antioxidants. A randomized, 38 
double-blind, multicenter trial was performed in athletes from 3 different sport clubs located in the 39 
southern region of Spain. Plasma oxidative stress markers (protein carbonyls and malondialdehyde 40 
(MDA)) as well as C-reactive protein and sE-selectin were measured. A total of 31 athletes 41 
participated in the study, supplemented during 21 days with 200 ml/day pomegranate juice (PJ) 42 
(n=10), 200 ml/day pomegranate juice diluted 1:1 with water (PJD) (n=11) and a control group not 43 
consuming pomegranate juice (C) (n=10). Nine volunteers were excluded due to protocol violations 44 
(n=4 in the PJ group and n=5 in the PJD group) since they did not respect the 24 h of rest before the 45 
last blood test. The control group increased levels of carbonyls (+0.7 ± 0.3 nmols/mg protein) and 46 
MDA (+3.2 ± 1.0 nmols/g protein), while PJ and PJD groups maintained or decreased their levels, 47 
respectively. On the other hand, lactate levels increased in the PJ group (from 10.3 at day 0 to 21.2 48 
mg/dL at day 22). A non-significant decrease was detected in sE-selectin and C-reactive protein in 49 
the groups consuming pomegranate juice. Consumption of pomegranate juice during 21 days 50 
improves MDA levels and carbonyls, decreasing the oxidative damage caused by the exercise.  51 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
3 
 
INTRODUCTION 52 
Reactive oxygen and nitrogen species (RONS) play various roles in the cells, being both 53 
beneficial and deleterious. The beneficial effects of RONS include defense against infectious 54 
agents as well as intracellular signaling molecules in many processes [1].  On the other hand, 55 
persistently high RONS levels can produce harmful effects if the antioxidant defenses are 56 
overwhelmed, resulting in structural damage, including membrane lipids, proteins and nucleic 57 
acids. This phenomenon is called oxidative stress, and can be detected by analyzing in blood 58 
end-metabolites of the oxidation process such as malondialdehyde (MDA) from lipid 59 
peroxidation, or by measuring oxidatively-altered macromolecules such as the presence of 60 
carbonyl adducts in affected proteins [2,3,4].  61 
Exercise could be considered as an exogenous source of oxidative stress due to an increase in 62 
oxygen consumption at the level of mitochondrial respiration, leading to punctual increases in 63 
RONS production [5].  However, this seems to be a controversial topic since the benefits of 64 
exercise are well documented in the prevention and/or treatment of chronic disorders such as 65 
diabetes mellitus, dyslipidemia, hypertension, obesity, cardiovascular and pulmonary 66 
diseases, muscle, bone and joint diseases, cancer and depression [6].  After moderately intense 67 
exercise, the muscle tissues produce RONS, which have been shown to act as intracellular 68 
secondary messengers [7].  However, when strenuous exercise or overloaded training is 69 
performed, an imbalance occurs between production of free radicals and the endogenous 70 
antioxidant systems [8,9,10]. Moreover, high levels of markers of oxidative stress and 71 
inflammation, such as E-selectin and CRP, could lead to endothelial dysfunction [11,12]. 72 
Nevertheless, diet is the main source of antioxidants and in this context, pomegranate juice, 73 
which is extracted from the fruit of the Punica granatum plant, is rich in polyphenols such as 74 
anthocyanins, flavonols and certain ellagitannins such as punicalagin [13]. Several studies 75 
have documented the benefits of pomegranate juice consumption in individuals affected with 76 
different disorders [14,15,16,17,18,19,20]. Regarding the field of physical activity, only a few 77 
studies have analyzed how pomegranate consumption can modulate performance during 78 
exercise [21,22].  However, there are no studies regarding the possible role of pomegranate 79 
juice consumption in oxidative stress modulation in athletes. Thus, the aim of the present 80 
study was to assess the effects of pomegranate juice on oxidative stress markers in a group of 81 
well-trained endurance-based athletes. 82 
MATERIAL AND METHODS 83 
Trial design 84 
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Participants were randomly assigned to one of the three groups that consumed the juice both 85 
training and non-training days. In the training days, juice intake was done just after the 86 
training session as a post-exercise meal: those that consumed a bottle of 200 ml/day of 87 
pomegranate juice (PJ group) (n=10), another group consumed a bottle of 200 ml/day 88 
pomegranate juice diluted 1:1 with water (PJD group) (n=11) and a control group that 89 
consumed fresh fruit (1 piece (200 g approx.) of seasonal fruit except pomegranate, which 90 
contains the same energy that 1 bottle (200 ml) of pomegranate juice) instead of pomegranate 91 
juice (C group) (n=8) for maintaining the same daily energetic intake (Table 1). The aim of a 92 
group taking a diluted form of PJ was to assess if there was a dose response in any of 93 
parameters studied. All the groups consumed fluids as water after exercise ad libitum. The 94 
design was a double-blind, parallel-group, randomized controlled trial conducted at Miguel 95 
Hernandez University of Elche (Spain). This work has been registered in: 96 
https://clinicaltrials.gov/ct2/show/NCT02293486, Protocol ID: GRA 01/ ClinicalTrials.gov 97 
ID: NCT02293486. 98 
 99 
Table 1: Anthropometric values of each group at day 0 (d0) and day 22 (d22). 100 
Group C (n=8) PJ (n=6) PJD (n=6) 
 Mean SD Mean SD Mean SD 
Age (years) 33.3  9.0 35.2  8.5 37.5  11.4 
Height (m) 1.7  0.1 1.7  0.1 1.7  0.1 
Weight (kg) (d0) 71.3 11.8 67.2 3.4 70.0 12.2 
Weight (kg) (d22) 70.3 11.7 66.8 3.8 70.1 12.1 
% Fat mass (d0) 14.2 4.4 15.7  6.0 16.3 5.4 
% Fat mass (d22) 13.1 4.2 14.5  5.2 15.7  4.8 
% Muscle mass (d0) 46.1 4.7 46.4 4.0 43.9 5.3 
% Muscle mass (d22) 46.3 4.6 46.7 4.2 43.3 4.8 
Exercise caloric expenditure (Kcal/day) 514.5 193.3 544.4 207.3 708.5 156.4 
Abbreviations used: C, control group not consuming pomegranate juice; PJ, group consuming 101 
pomegranate juice; PJD, group consuming pomegranate juice diluted 50% with water; d, day. 102 
There are not significant differences between groups in the parameters analysed. 103 
 104 
Participants 105 
Volunteers participating in the study (Table 1) were selected from sport clubs of different 106 
locations in southeastern Spain. The parameters for inclusion were to be adult males, perform 107 
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training sessions, and to have participated recently in a half marathon or similar event, which 108 
are held throughout the competitive season. To this end, the participants performed 109 
endurance-based training for more than 1h per session and more than 3 sessions per week. 110 
The exclusion criteria were: intake of antioxidant or anti-inflammatory supplementation, 111 
present a chronic disorder, smoker and alcoholic beverage consumption.  112 
Interventions 113 
Thirty-one volunteers were selected (Fig. 1), informed about the objective and demands of the 114 
study and gave their written consent to participate. The protocol was in accordance with local 115 
legal requirements and the Helsinki Declaration for research on human beings, and approved 116 
by the Ethics Committee of University Miguel Hernandez.  117 
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Fig. 1. Participant’s flow diagram. 118 
Pomegranate juice was provided by Vitalgrana SL®, elaborated by crushing the fruit and the 119 
seed. This produces the transfer of an oily phase to the final juice that is rich in unsaturated 120 
fatty acids, being punicic acid one of the most abundant. The complete composition of the 121 
juice is provided in (http://www.vitalgrana.com/es/productos-zumo-granada). The study 122 
lasted a total of 5 weeks (Fig. 1). The first two weeks of the experiment (homogenization 123 
period) were used to volunteers started their training sessions and verify accomplishment of 124 
the duration and frequency, to accustom volunteers to the individual diet plan and to solve 125 
doubts about the procedure. During the homogenization period, 9 volunteers were excluded 126 
due to protocol violations in the training program (Fig. 1). The recruitment process began in 127 
August 2012, and the intervention was carried out in February 2013. 128 
 129 
Table 2: Energy and macronutrient composition of diets used in the study. 130 
Abbreviations used: CHO, carbohydrate; P, protein; F, fats. 131 
 132 
Diet plans were customized adjusting energy expenditures and macronutrients to the training 133 
activity and body weight (Table 2) in order of the diet composition or energy intake did not 134 
affect the study. Total energy expenditure (TEE) was estimated as an average of the rest 135 
energy expenditure (REE) for each weight range according to the FAO equation 136 
([11.3·weight] + [16· [height/100]] +901) [21] and multiplied by 1.55 as a factor for activity. 137 
Therefore, all groups had the same diet plan according to the individual weight, with the only 138 
exception of the change of one portion of fruit in group C by the juice in groups PJ and PJD in 139 
order to maintain the energy intake. The subjects were instructed to manage their own diet 140 
plan by making proper equivalent food changes (maintaining the daily energy intake and 141 
macronutrient composition approximately) during the 3 weeks of intervention. Periodic 142 
meetings or email contact was maintained to solve any doubts the volunteers had during the 143 
Weight range 
(kg) 
kJ/day % 
CHO 
g/kg·day 
CHO 
% 
P 
g/kg·day 
P 
% 
F 
g/kg·day 
F 
55 – 59 9,630  
65 
6.3 – 6.7  
15 
 
1.4 – 1.5  
20 
 
1.2 – 1.3 
60 – 65 10,467 6.3 – 6.8 1.4 – 1.5 1.1 – 1.2 
66 – 70 10,886 6.0 – 6.4 1.5 1.1 – 1.2 
71 - 75 11,723 6.0 – 6.3 1.4-1.5 1.0 – 1.1 
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study. The next three weeks were considered as the intervention period when data was 144 
collected, coinciding with other studies that used similar periods of time [14,24]. At day 0, 145 
before starting the intervention and 48h without exercise, whole blood samples were collected 146 
and anthropometric measures performed according to recommendations of the International 147 
Society for Advancement of Kinanthropometry (ISAK).  At the end of the study (day 22), 148 
volunteers repeated the above mentioned procedures. The subjects scored during the 22 days 149 
of intervention their physical activity and its duration. The energy expenditure by exercise of 150 
each subject was calculated through MET values of each activity and shown as the main of 151 
energy consumed per day (Table 1).  152 
Blood samples were obtained from the antecubital vein in EDTA vacutainers at days 0 and 22 153 
after overnight fasting. The plasma was obtained as a supernatant of the whole blood after 154 
centrifugation at 1000xg for 15 min at 4ºC and then stored at -80º C. 155 
Circulating glucose was determined by the glucose oxidase method coupled to the peroxidase 156 
reaction [25]. HDL-cholesterol was determined by a direct enzymatic colorimetric method. 157 
HDL was dissolved with a detergent, while HDL-cholesterol was released to react with 158 
cholesterol esterase. Afterwards, free cholesterol was oxidized with cholesterol oxidase to 159 
cholest-4-ene-3-one and hydrogen peroxide, which was determined using the peroxidase 160 
reaction. The non-HDL lipoproteins were inhibited from reacting with the enzymes due to the 161 
absorption to the detergent [26]. Circulating triglycerides were determined from coupled 162 
reactions of lipoprotein-lipase, glycerol-kinase, glycerol phosphate oxidase and peroxidase, 163 
giving a color end-adduct as reported previously [27].  Ferritin was determined using an 164 
enzyme-linked fluorescent assay (BioMerieux, Madrid, Spain) according to the 165 
manufacturer´s instructions. Lactate was determined by lactate oxidase/peroxidase-coupled 166 
colorimetric reaction [28].  Plasma Na+ and K+ were determined by potentiometry using 167 
selective electrodes Spotlyte (Menarini, Badalona, Spain). Creatine kinase was determined 168 
photometrically (Spinreact, Girona, Spain) from coupled reactions of hexokinase and glucose-169 
6-phosphate dehydrogenase, giving rise to NADPH. Aspartate aminotransferase (AST) was 170 
determined photometrically (Spinreact, Girona, Spain) by analyzing the decreased NADH 171 
concentration from the coupled reaction with malate dehydrogenase. Alanine 172 
aminotransferase (ALT) was determined in a similar manner as AST, only the coupled 173 
reaction was performed on lactate dehydrogenase.  174 
Oxidative stress markers were determined in plasma. Protein carbonyl derivatives were 175 
determined using an adaptation of the method published in Levine et al [29].  MDA was 176 
determined by HPLC with fluorescence detection according to the method described by 177 
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Laporta et al [30].  Briefly, 100 µl of plasma were mixed with 100 µl of 0.05% butylated 178 
hydroxytoluene in ethanol and 100 µl of 20% trichloroacetic acid in 0.6M HCl. The samples 179 
were incubated 15 min on ice and then centrifuged at 5000xg during 15 min at 4ºC. The 180 
supernatant was collected and 100 µl of 0.6% thiobarbituric acid (TBA) in water was added. 181 
Then, the mixture was incubated at 97ºC for 30 min, allowed to cool down and extracted with 182 
200 µl of n-butanol through vigorous shaking. Finally, the samples were centrifuged at 183 
10000xg for 3 min at 4ºC. The TBA–MDA chromogen was determined using a HPLC and 184 
fluorescence detection system. 185 
Cytokine concentrations in plasma, specifically C-reactive protein (CRP) and sE-selectin, 186 
were determined in 25 µl of plasma by an immunoassay analyzed on a flow cytometer (BD 187 
FacsCanto II, San Jose, CA, USA) according to the manufacturer’s instructions (eBioscience, 188 
San Diego, CA, USA). The lower limits of detection were: 67.0 ng/l for CRP and 1.2 ng/ml 189 
for sE-selectin. 190 
Outcomes 191 
The primary endpoint was to assess whether pomegranate juice consumption can modulate 192 
changes in plasma protein carbonyls and MDA levels in volunteers. The secondary endpoint 193 
was to assess whether the same supplements can modulate changes in plasma markers related 194 
to the health status of each individual during the study. 195 
Blinding 196 
During the intervention, the participants, investigator and outcome assessor were blinded. 197 
Neither the group nor the volunteers knew who and what supplement were the other 198 
participants taking during the 22 days of the study. Participating groups were also unaware of 199 
the type of drink they were consuming, or of the existence of other volunteers in different 200 
locations. In this manner, it was not necessary for the flavor to be blinded. The groups were 201 
blinded by letters and each participant by numbers, indicating the first samples as d0 and the 202 
last samples as d22 to blind the investigator, which was given by the outcomes assessor. 203 
Finally, when the results were obtained, the investigator changed the codes before giving 204 
them to the outcomes assessor.  205 
Statistical methods and sample size 206 
Statistical analysis was performed using the Statistical Package for Social Sciences (SPSS, v. 207 
20.0 for Windows) to process the data obtained from the volunteers. Standard descriptive 208 
statistics were presented as mean ± standard deviation (SD) (mean ± SD). Since the 209 
volunteers presented different values in the circulating parameters analyzed at the beginning 210 
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of the study, the differences in values between day 0 and 22 were analyzed in each group 211 
using a transversal analysis. The difference between both values (∆parameter = parameterday22 212 
– parameterday0) indicated the variation underwent by each parameter, positive values reported 213 
an increase in the corresponding parameter, while negative values indicated a decrease. One-214 
sample K-S test (Kolmogorov-Smirnov test) and Homoscedasticity Levene test were 215 
performed in order to assess if the variables fit a normal distribution. Due to the volunteer 216 
exclusions during the study, the n of all groups was between 6 and 8 athletes. Therefore, non-217 
parametric tests for dependent samples (Wilcoxon test) were used when comparing the intra-218 
group variation between day 0 and day 22. A non-parametric two-way analysis of variance 219 
(Kruskal-Wallis) was used to test the inter-group effect of juice consumption and aerobic 220 
training after 22 days.  Values with a p<0.05 were considered significant. 221 
RESULTS 222 
Effect of pomegranate juice consumption in plasma circulating parameters 223 
No variation in body composition or weight was detected in any of the volunteers during the 224 
experimental protocol. In a comparative analysis between days 0 and 22, glucose tended to 225 
increase in all groups, although always in the healthy range, being most significant in the C 226 
and PJD group (Table 3).  227 
 228 
Table 3: Significant changes in plasma parameters of each group comparing day 0 and 22 229 
Group C (n=8) PJ (n=6) PJD (n=6) 
Day 0 22 0 22 0 22 
 Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Glucose (mg/dL) 74.4  9.5 80.5  13.0* 79.0  8.0 80.8  9.7 73.3  8.0 83.3  5.3* 
HDL (mg/dL) 41.9  4.6 42.9  6.5 53.3  10.2 54.3 11.1 48.8  7.3 51.0  7.0* 
AST (U/L) 29.5  5.8 23.5  4.3* 22.5  2.7 24.5  3.4 24.2  4.0 29.2  15.7 
ALT (U/L) 21.2  5.9 18.4  5.2 17.0  3.0 22.0  11.4 17.0  3.4 25.2  13.6 
K+ (mEq/L) 4.2  0.2 4.2   0.3 4.1   0.1 4.4   0.2* 4.3  0.3 4.3  0.4 
Na+ (mEq/L) 139.1  1.5 139.1  1.0 139.5  0.7 139.5  0.5 139.2  1.2 139.4  1.0 
Lactate (mg/dL) 8.9   3.4 10.1  5.8 10.3  2.0 21.2  4.5 † 7.9  4.9 13.7  9.2 
Ferritine (ng/mL) 71.7  39.6 65.1  38.4 69.2  37.4 55.0  36.7* 58.7  27.9 57.6  12.7 
             
Abbreviations used: C, control group not consuming pomegranate juice; PJ, group consuming 230 
pomegranate juice; PJD, group consuming pomegranate juice diluted 50% with water. 231 
*p<0.05 versus day 0; † p<0.01 versus day 0. 232 
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 233 
Similarly, lactate also tended to increase and ferritine to decrease in all groups, being only 234 
significant in the PJ group. As for the change score of lactate (∆lactate), all groups tended to 235 
increase, being significantly higher in PJ than C (Table 4).  236 
 237 
            Table 4: Significant change scores in biochemical plasma parameters between groups at the 238
end of the study. 239 
Groupa C (n=8) PJ (n=6) PJD (n=6) 
 Mean SD Mean SD Mean SD 
∆Glucose (mg/dL) 6.1  4.9 1.8  10.0 10.0   6.2 
∆HDL (mg/dL) 1.0   4.0 1.0  2.8 2.2   1.5 
∆AST (U/L) -6.0   6.1 2.0   3.0 5.0   14.5 
∆ALT (U/L) -2.9  5.6 5.0   10.1 8.2   14.0 
∆K+ (mEq/L) 0.1   0.2 0.3   0.3 0.0   0.3 
∆Na+ (mEq/L) 0.0  1.5 0.0   0.9 0.2   0.8 
∆Lactate (mg/dL) 1.2   3.9 10.9   6.0* 5.9   8.7 
∆Ferritine (ng/mL) -6.6  20.8 -14.2   3.9 -1.1   18.2 
 
      
Abbreviations used: C, control group not consuming pomegranate juice; PJ, group consuming 240 
pomegranate juice; PJD, group consuming pomegranate juice diluted 50% with water. a∆ = 241 
(value obtained at day 21) - (value obtained at day 1).*p<0.05 C versus PJ.  242 
 243 
On the other hand, the study of damage tissue markers showed that transaminases (AST and 244 
ALT) tended to increase no significantly during the 3 weeks of intervention only in PJ and 245 
PJD groups, but not in  group, where AST decreased significantly at day 22 (Table 3). No 246 
significant differences were observed in the change scores of transaminases between groups 247 
(Table 4) possibly due to the need of more intervention days for these changes to be 248 
significant. Parameters related with lipid metabolism showed an increase in HDL cholesterol 249 
in all groups at the end of the study, being significant only in the PJD group (table 3). As in 250 
the case of the transaminases, no differences were observed in the changes of HDL levels 251 
when compared between the groups (table 4). Finally, the electrolyte status reflected by the 252 
determination in plasma of K+ and Na+ presented only significant changes for K+ at the end of 253 
the study in the PJ group (Table 3), albeit in the healthy range in all cases. Na+ levels were 254 
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stable in all groups. No differences in K+ and Na+ were detected between groups when 255 
analyzing their change scores (∆K+ and ∆Na+). 256 
Effect of pomegranate juice consumption in plasma protein carbonyls and MDA 257 
Significant differences were observed in oxidative stress markers MDA and protein carbonyls 258 
both between groups as well as in the change scores (∆carbonyls and ∆MDA) (Fig. 2). At day 259 
22, protein carbonyl levels significantly increased in C group (passing from 1.1 at day 0 to 1.8 260 
nmols/mg protein at day 22), while PJ and PJD groups presented no significant changes (Fig. 261 
2). In the case of MDA, C group also presented a significant increase at the end of the study 262 
(14.1 nmols/g protein) compared to day 0 (10.9 nmols/g protein). On the other hand, 263 
decreased MDA levels were detected in PJ and PJD groups in the same time period (Fig. 2). 264 
Fig. 2. Changes in carbonyls and MDA levels (a and b respectively) between days 0 and 22 265 
during the consumption of PJ (dashed squares), PJD (empty squares) and C (black squares). 266 
*P< 0.01 versus day 0. Change scores and comparison between PJ, PJD and C groups (c and 267 
d). † P< 0.01 versus C. 268 
 269 
Effect of pomegranate juice consumption in CRP and sE-selectin  270 
None of the groups presented changes in CRP and sE-selectin levels throughout the 271 
experiment (not shown). However, a slight but not significant decrease in sE-selectin levels 272 
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was detected in PJ and PJD groups (-4.2 ± 23.3 ng/ml and -1.5 ± 9.5 ng/ml respectively), 273 
while the contrary was detected in the C group. On the other hand, a no significantly decrease 274 
was detected in the change scores for CRP (∆CRP) of the PJD group (-0.7 ± 1.3 mg/l).  275 
DISCUSSION 276 
The present study assess the impact of pomegranate juice in the oxidative status of endurance-277 
based athletes after consuming the beverage for over three weeks. All hematological and 278 
biochemical blood parameters were in the healthy range, and the variations detected were not 279 
related to any pathological process.  280 
Trial limitations 281 
The limitations that the study presents stem from the low number of volunteers due to the 282 
strict selection criteria used during the randomization trial. Despite the low number, there was 283 
a high rate of homogeneity in terms of gender, age, body composition and training routine. 284 
On the other hand, for more exhaustive control of the  diet adherence, a 24h recall 285 
questionnaires would be made every week.  286 
External validity and applicability of the trial findings 287 
The volunteers of this study were chosen from different sport clubs in Southeastern Spain. 288 
Nevertheless, we can state that the results could be applicable to adult males that frequently 289 
practice endurance-based sports, but further investigation of the use of pomegranate juice in 290 
endurance sport athletes need to be replicated in larger clinical trials. 291 
Blood biochemical parameters. 292 
Interestingly, lactate levels were higher in the PJ group at the end of the intervention period 293 
(10.3 at day 0 vs 21.2 mg/dl at day 22). Significant differences were also detected when 294 
comparing lactate levels between PJ vs C group. It is well known that lactate increase occurs 295 
during high-intensity exercise, as pyruvate conversion to lactate is a rapid method to obtain 296 
energy. In this context, the PJ group presented increased K+ levels at the end of the study, 297 
although the differences compared to the other groups were not significant. A likely 298 
explanation to these observations is that high intensity exercise tends to increase extracellular 299 
K+ levels in order to maintain an optimal muscle contractibility [31], playing a parallel role 300 
with lactate against muscular fatigue [32].  It must take in account that a bottle of PJ contains 301 
roughly 600mg of potassium and PJD and 200g of seasonal fresh fruit have 300 and 200-302 
500mg respectively, thus it will also validate the role of the daily potassium intake to test his 303 
role in these blood changes. The results of this experiment, together with a significant 304 
decrease in AST (an aminotransferase that is released from the muscle after a high intensity 305 
exercise) [33] in the C group compared to the other groups, give rise to the hypothesis that 306 
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pomegranate juice intake could have optimized the training intensity during the period of 307 
study, improving the wellness or maybe the capacity of fatigue perception during the training 308 
sessions through an unknown mechanism. Differences in AST clearance from circulation 309 
between different groups should be taken into account as well. Further studies taking in 310 
account the percentage of VO2max during the training sessions are necessary for a proper 311 
validation.  312 
Only PJD group improve significantly HDL levels at day 22 although PJ group maintained a 313 
higher level than PJD even at day 0. Recent studies in animal models have demonstrated that 314 
consumption of pomegranate juice reduce the risk of atherogenicity [34,35]. 315 
Oxidative stress markers 316 
Recent studies indicate that 15 days of pomegranate juice consumption reduces MDA, 317 
carbonyls and matrix metalloproteinases 2 and 9 levels and increases erythrocyte glutathione 318 
contents, serum superoxide dismutase and glutathione peroxidase levels in healthy non-active 319 
volunteers [24,36]. The most interesting observation of that study was that the antioxidant 320 
beneficial effects of the juice persisted 3 weeks after consumption was halted [24]. In our 321 
study, and despite the direct implication of pomegranate juice consumption in the changes 322 
observed in circulating lipids, neither PJ nor PJD groups presented significant changes in the 323 
lipid parameters. In this respect, it must be mentioned that all subjects participating in the 324 
study (C, PJ and PJD) presented healthy values in all parameters related to the circulating 325 
lipid profile, making it difficult to observe positive changes. This is in agreement with other 326 
previously published reports using either sedentary volunteers or hemodialysis patients 327 
[23,20]. In any case, the next question would be to identify the candidate components in 328 
pomegranate juice that may be responsible for the changes in circulating lipid parameters. For 329 
example, the polyphenols may be an appropriate candidate, due to their affinity to plasma 330 
lipid molecules [37]. In the present study, pomegranate juice consumption is capable of 331 
decreasing the initial MDA levels in a greater extent than plasma carbonyls. However, this 332 
seems to be dependent on the body compartment analyzed. For instance, mouse liver 333 
homogenates presented significantly decreased carbonyl content and 8-OH-guanosine levels, 334 
while MDA levels were not affected after four weeks of pomegranate juice consumption [19]. 335 
Several mechanisms have been proposed to explain the antioxidant effect of polyphenols. 336 
These include free radical scavenging, antioxidant recycling, antioxidant enzyme activity 337 
modulation and preservation of mitochondrial function [38]. In this context, the studies 338 
concerning polyphenol concentrations reveal that the inner and outer peels possess higher 339 
levels than the seeds [18].  Altogether, these observations strongly indicate that the method of 340 
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juice manufacturing is an instrumental factor in the final composition. The juice used in this 341 
study contains a mixture of inner and outer peels as well as from the seed. Therefore, the 342 
antioxidant capacity of the product tested in this study could be considered higher than that 343 
from other juices that do not use these subproducts. In addition, it has been well documented 344 
that pomegranate juice possesses higher levels of antioxidants than other beverages, including 345 
red wine, green tea or wine vinegars[13, 39].   346 
Plasma citokynes 347 
The levels of sE-selectin, a specific marker of endothelial dysfunction and associated with 348 
diabetes, tends to decrease in a non-significant manner in PJ and PJD groups. These results 349 
are in agreement with studies where adolescents with metabolic syndrome consumed 350 
pomegranate juice [16], but not in cases where hypertensive volunteers were analyzed [15].  351 
CRP is also a marker for endothelial dysfunction and vascular inflammation. In the present 352 
study, pomegranate consumption did not significantly affect this parameter, whose values 353 
were inside healthy ranges (0.8-1.7 mg/l) before and after intervention, which corroborates the 354 
results observed in other studies with subjects with hypertension or metabolic disorders 355 
[15,16]. On the other hand, the levels of CRP tend to decrease significantly in healthy subjects 356 
with the consumption of pomegranate juice, but the baseline of their CRP values was 357 
unusually very high (6.4-6.8 mg/l) in that study [36]. So those changes could be due to the 358 
wide range of improvement that the subjects had. In this sense, it could be interesting to 359 
analyze the profile of cytokines that are related to exercise performance, such as tumor 360 
necrosis factor−α (TNF-α) [40] or interleukin-6 (IL-6), which act over the expression of 361 
endothelial adhesion molecules such as sE-selectin [41]. Further studies are necessary to 362 
confirm this point in physically-active volunteers. 363 
CONCLUSION 364 
In conclusion, and taking in account the data presented in this study, consumption of 365 
pomegranate juice during 22 days is capable of modulating fat and protein damage, as the 366 
changes in MDA and carbonyl levels indicated. The high presence of antioxidant polyphenols 367 
also supports this recommendation. Finally, the evaluation of pomegranate juice consumption 368 
regarding training intensity, as well as the study of circulating parameters such as blood 369 
lactate, K+ and AST, needs to be analyzed in further studies.  370 
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Table 1: Anthropometric values of each group at day 0 (d0) and day 22 (d22).. 
Group C (n=8) PJ (n=6) PJD (n=6) 
 Mean SD Mean SD Mean SD 
Age (years) 33.3  9.0 35.2  8.5 37.5  11.4 
Height (m) 1.7  0.1 1.7  0.1 1.7  0.1 
Weight (kg) (d0) 71.3 11.8 67.2 3.4 70.0 12.2 
Weight (kg) (d22) 70.3 11.7 66.8 3.8 70.1 12.1 
% Fat mass (d0) 14.2 4.4 15.7  6.0 16.3 5.4 
% Fat mass (d22) 13.1 4.2 14.5  5.2 15.7  4.8 
% Muscle mass (d0) 46.1 4.7 46.4 4.0 43.9 5.3 
% Muscle mass (d22) 46.3 4.6 46.7 4.2 43.3 4.8 
 
Abbreviations used: C, control group not consuming pomegranate juice; PJ, group 
consuming pomegranate juice; PJD, group consuming pomegranate juice diluted 50% with 
water; d, day. 
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Table 2: Energy and macronutrient composition of diets used in the study. 
 
 
 
 
Abbreviations used: CHO, carbohydrate; P, protein; F, fats. 
 
 
 
 
Weight range (kg) kJ/day % CHO g/kg·day CHO % P g/kg·day P % F g/kg·day F 
55 – 59 9,630  
65 
6.3 – 6.7  
15 
 
1.4 – 1.5  
20 
 
1.2 – 1.3 
60 – 65 10,467 6.3 – 6.8 1.4 – 1.5 1.1 – 1.2 
66 – 70 10,886 6.0 – 6.4 1.5 1.1 – 1.2 
71 - 75 11,723 6.0 – 6.3 1.4-1.5 1.0 – 1.1 
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Table 3: Significant changes in plasma parameters of each group comparing day 0 and 22 
Group C (n=8) PJ (n=6) PJD (n=6) 
Day 0 22 0 22 0 22 
 Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Glucose (mg/dL) 74.4  9.5 80.5  13.0* 79.0  8.0 80.8  9.7 73.3  8.0 83.3  5.3* 
HDL (mg/dL) 41.9  4.6 42.9  6.5 53.3  10.2 54.3 11.1 48.8  7.3 51.0  7.0* 
AST (U/L) 29.5  5.8 23.5  4.3* 22.5  2.7 24.5  3.4 24.2  4.0 29.2  15.7 
ALT (U/L) 21.2  5.9 18.4  5.2 17.0  3.0 22.0  11.4 17.0  3.4 25.2  13.6 
K+ (mEq/L) 4.2  0.2 4.2   0.3 4.1   0.1 4.4   0.2* 4.3  0.3 4.3  0.4 
Na+ (mEq/L) 139.1  1.5 139.1  1.0 139.5  0.7 139.5  0.5 139.2  1.2 139.4  1.0 
Lactate (mg/dL) 8.9   3.4 10.1  5.8 10.3  2.0 21.2  4.5 † 7.9  4.9 13.7  9.2 
Ferritine (ng/mL) 71.7  39.6 65.1  38.4 69.2  37.4 55.0  36.7* 58.7  27.9 57.6  12.7 
             
Abbreviations used: C, control group not consuming pomegranate juice; PJ, group consuming pomegranate juice; PJD, group consuming 
pomegranate juice diluted 50% with water. *p<0.05 versus day 0; † p<0.01 versus day 0. 
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Table 4: Significant change scores in biochemical plasma parameters between groups at the end 
of the study. 
Groupa C (n=8) PJ (n=6) PJD (n=6) 
 Mean SD Mean SD Mean SD 
∆Glucose (mg/dL) 6.1  4.9 1.8  10.0 10.0   6.2 
∆HDL (mg/dL) 1.0   4.0 1.0  2.8 2.2   1.5 
∆AST (U/L) -6.0   6.1 2.0   3.0 5.0   14.5 
∆ALT (U/L) -2.9  5.6 5.0   10.1 8.2   14.0 
∆K+ (mEq/L) 0.1   0.2 0.3   0.3 0.0   0.3 
∆Na+ (mEq/L) 0.0  1.5 0.0   0.9 0.2   0.8 
∆Lactate (mg/dL) 1.2   3.9 10.9   6.0* 5.9   8.7 
∆Ferritine (ng/mL) -6.6  20.8 -14.2   3.9 -1.1   18.2 
 
      
Abbreviations used: C, control group not consuming pomegranate juice; PJ, group consuming 
pomegranate juice; PJD, group consuming pomegranate juice diluted 50% with water. a∆ = (value 
obtained at day 21) - (value obtained at day 1).*p<0.05 C versus PJ.  
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Highlights 
• The intake of pomegranate juice as antioxidant supplement is proposed. 
• The level of oxidative stress markers was measure in endurance-based athletes after 
supplementation. 
• The level of circulating cytokines was measure in endurance-based athletes after 
supplementation   
• MDA and carbonyls decrease signifcantly after 22 days of pomegrante juice 
supplementation. 
• No changes in circulating cytokines levels after 22 days of pomegrante juice 
supplementation. 
 
